Treatment of Acute Venous Thromboembolism

Authors

Sashi N. Nair, Henry Ford HealthFollow
Nina Garza, Henry Ford HealthFollow
Matt George, Henry Ford HealthFollow
Scott Kaatz, Henry Ford HealthFollow

Recommended Citation

Nair S, Garza N, George M, and Kaatz S. Treatment of Acute Venous Thromboembolism. Med Clin North Am 2020; 104(4):631-646.

Document Type

Article

Publication Date

7-1-2020

Publication Title

The Medical clinics of North America

Abstract

Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections.

Medical Subject Headings

Administration, Oral; Anticoagulants; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pulmonary Embolism; Risk Assessment; Surgical Procedures, Operative; Venous Thromboembolism; Venous Thrombosis; Vitamin K

PubMed ID

32505257

Volume

104

Issue

4

First Page

631

Last Page

646